Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Genmab achieves second milestone in daratumumab collaboration with Janssen

March 28, 2014

Mologen initiates lung cancer trial of MGN-1703 in Belgium

March 27, 2014

Siltuximab receives positive CHMP opinion supporting approval in multicentric Castleman's disease

March 25, 2014

ArevaMed presents phase I data for 212Pb-TCMC-trastuzumab

March 24, 2014

Phase III trial of GSK's MAGE-A3 immunotherapeutic in NSCLC misses first co-primary endpoints

March 21, 2014

Advaxis and UCSF to assess cancer immunotherapy constructs

March 19, 2014

Igenica Biotherapeutics doses first patient in phase I study of IGN-523

March 19, 2014

Japanese approval for Poteligeo in PTCL and CTCL

March 17, 2014

U.S. researchers prepare new MAbs for diagnostic and treatment of cancer

March 17, 2014

Peregrine Pharmaceuticals' PS-targeted programs supported by recent preclinical data

March 14, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 29, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...